Recent Finacing
Recent Raise
SparingVision is a French biotech developing mutation-agnostic AAV gene therapies for inherited retinal diseases, advancing SPVN06—an AAV delivering neurotrophic and antioxidative genes—toward GMP production and first-in-human trials.
